We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.35%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$585M
AUM Growth
+$25.3M
(+4.5%)
Cap. Flow
-$29M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
46.14%
Holding
338
New
9
Increased
8
Reduced
156
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$3.6M |
| 2 |
NVIDIA
NVDA
|
+$1.81M |
| 3 |
Natera
NTRA
|
+$1.51M |
| 4 |
Pfizer
PFE
|
+$1.41M |
| 5 |
SentinelOne
S
|
+$706K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.86M |
| 2 |
Microsoft
MSFT
|
+$2.82M |
| 3 |
Mastercard
MA
|
+$2.78M |
| 4 |
Comcast
CMCSA
|
+$2.56M |
| 5 |
Apple
AAPL
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35% |
| 2 | Healthcare | 14.27% |
| 3 | Consumer Discretionary | 13.55% |
| 4 | Communication Services | 11.79% |
| 5 | Financials | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCPC
101
Balchem Corp
BCPC
$5.38B
| $883K | 0.15% |
5,216
-335
| -6% | -$53.8K |
|
102
KKR & Co
KKR
$91.1B
| $877K | 0.15% |
11,766
| – | – |
|
103
Phillips 66
PSX
$84.9B
| $847K | 0.14% |
11,687
-691
| -6% | -$52.2K |
|
|
DOCU
104
DocuSign
DOCU
$10.5B
| $830K | 0.14% |
5,446
-239
| -4% | -$54.5K |
|
105
Casella Waste Systems
CWST
$5.71B
| $804K | 0.14% |
9,413
-1,653
| -15% | -$139K |
|
106
Chemed
CHE
$7.07B
| $790K | 0.14% |
1,493
-96
| -6% | -$46.1K |
|
107
Inspire Medical Systems
INSP
$1.45B
| $769K | 0.13% |
3,343
-214
| -6% | -$52.3K |
|
108
AbbVie
ABBV
$443B
| $647K | 0.11% |
4,777
| – | – |
|
109
10x Genomics
TXG
$6B
| $626K | 0.11% |
4,202
-327
| -7% | -$50.1K |
|
110
Wingstop
WING
$3.53B
| $607K | 0.1% |
3,510
-225
| -6% | -$37.7K |
|
111
Simpson Manufacturing
SSD
$7.72B
| $593K | 0.1% |
4,264
-274
| -6% | -$33.1K |
|
112
Intercontinental Exchange
ICE
$85.6B
| $573K | 0.1% |
4,193
| – | – |
|
113
Herc Holdings
HRI
$5.02B
| $571K | 0.1% |
3,646
-879
| -19% | -$155K |
|
114
Cisco
CSCO
$457B
| $554K | 0.09% |
8,736
| – | – |
|
|
GTLS
115
DELISTED
Chart Industries
GTLS
| $553K | 0.09% |
3,467
-845
| -20% | -$149K |
|
116
FormFactor
FORM
$8.28B
| $530K | 0.09% |
11,597
-745
| -6% | -$30.5K |
|
117
Five Below
FIVE
$12B
| $525K | 0.09% |
2,539
-163
| -6% | -$32.1K |
|
118
Intel
INTC
$455B
| $484K | 0.08% |
9,404
| – | – |
|
119
Churchill Downs
CHDN
$5.88B
| $471K | 0.08% |
3,900
-1,500
| -28% | -$178K |
|
120
Monarch Casino & Resort
MCRI
$2.2B
| $452K | 0.08% |
6,113
-393
| -6% | -$27.4K |
|
121
Texas Roadhouse
TXRH
$13.5B
| $442K | 0.08% |
4,948
-3,594
| -42% | -$320K |
|
122
WD-40
WDFC
$3.05B
| $427K | 0.07% |
1,747
-112
| -6% | -$26.1K |
|
123
Johnson & Johnson
JNJ
$618B
| $423K | 0.07% |
2,471
| – | – |
|
124
Ross Stores
ROST
$80.5B
| $414K | 0.07% |
3,621
| – | – |
|
125
Procter & Gamble
PG
$336B
| $411K | 0.07% |
2,513
| – | – |
|
Similar funds
AG
NRCM
BAM
PFM
DMIC
LIP
CCM
HCC
Silvant Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Silvant Capital Management held 338 positions worth $585M, up 4.5% from $560M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Silvant Capital Management withdrew a net $29M in Q4 2021, closing 5 positions and reducing 156 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $350K position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Silvant Capital Management opened a new position in Netflix worth $3.4M.
- Silvant Capital Management's largest Q4 2021 buy was Netflix: 56,410 shares worth $3.4M.
- Silvant Capital Management added most to NVIDIA in Q4 2021, an estimated $1.81M increase.
- Silvant Capital Management's biggest Q4 2021 reduction was Visa, cutting an estimated $4.86M.
- Silvant Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $350K.
- Silvant Capital Management's ten largest holdings make up 46% of its $585M portfolio in Q4 2021.
- Silvant Capital Management opened 9 new positions and closed 5 in Q4 2021.
- Silvant Capital Management's portfolio value rose 4.5% quarter-over-quarter to $585M.
Based on Silvant Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.